Presidio Management Group X LLC

This profile gathers the share dealings of Presidio Management Group X LLC across 3 companies, led by eFFECTOR Therapeutics, Inc., Inari Medical, Inc. and Castlight Health, Inc. Over a trading history stretching from 19 March 2014 to 3 August 2022, the count stands at 111 filings.

The open-market side counts 1 purchase for €1.7M alongside 79 sales for €3.8M. Netting one side against the other leaves €2.1M of net selling. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. 2022 to date brings no purchases and 44 sales.

On 3 August 2022 came the latest disclosure, an open-market sale for €1,422 in eFFECTOR Therapeutics, Inc. The latest purchase dates back some time: it was published 2,341 days ago, on 27 May 2020. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.